Pete Gagnon, Chief Scientific Officer of BIA Separations, has worked with most of the major international biopharma companies, dozens of start-ups and intermediate size companies, and nearly all of th ...
Antibiotics are unable to keep pace with infectious diseases, and the use of bacteriophages is a timely solution to that problem. But implementation of bacteriophages involves overcoming some challeng ...
CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs).
Portfolio includes n ...
• GeneX India Biosciences takes over sole distribution activities in India
• IT Technologies will operate in Singapore and Malaysia Ajdovščina, Slovenia, 08 July 2020: BIA Separations, a lead ...
Combination of businesses will create a premium portfolio for advanced therapies. BIA Separations will be Sartorius’ center of excellence for purification of cell and gene therapeutics. The life sc ...
...
...
We are happy to announce that BIA Separations, now part of Sartorius group, welcomed a new team member: Rok Sekirnik, PhD was appointed as Head of Process Development mRNA/pDNA at the beginning of thi ...
...
Last week BIA Separations attended an IMAPAC event, the 4th Annual Vaccine Congress which took place in Hyderabad, India from March 4 to March 6.
At the event the latest directives in the vaccine ind ...